Unilateral biportal endoscopic (UBE) spinal surgery involves two separate portals for viewing and working. If the outflow of irrigation fluid between portals is blocked, it can result in increased cerebrospinal fluid pressure, potentially leading to elevated intracranial pressure and related neurological complications. This sudden increase in intracranial pressure may cause transient cerebral hypoperfusion, manifesting as an isoelectric pattern on bispectral index (BIS) monitoring. This study aimed to investigate the use of BIS monitoring as an early indicator of increased intracranial pressure. BIS monitoring was conducted on patients undergoing UBE surgery to noninvasively detect sudden increases in intracranial pressure. Cases with a follow-up period of less than twelve months were excluded. Intraoperative BIS values of the patients and postoperative neurological complications were retrospectively evaluated. As of May 2023, BIS monitoring started to be conducted on all patients undergoing UBE surgery in our clinic. Between May and December 2023, 182 levels of endoscopic spinal surgery were performed on 111 patients. The isoelectric BIS pattern was observed intraoperatively in six of these patients. Among them, 1 patient experienced left retinal vein hemorrhage due to increased intracranial pressure. No neurological complications were observed in the remaining five patients. BIS monitoring is a noninvasive technique that can indicate cerebral hypoperfusion due to sudden increases in intracranial pressure. Thus, BIS monitoring should be considered a valuable tool in the management of patients undergoing UBE spine surgery, aiding in the early detection and appropriate treatment of central nervous system complications.
Background/Objectives: To compare perioperative cytokine profiles, four-month chronic pain, acute analgesia, and recovery among women receiving intrathecal morphine (ITM) or erector spinae plane block (ESPB) after elective caesarean delivery. Methods: In this prospective observational cohort, 88 women received ITM (50 μg; n = 44) or bilateral ESPB (0.25% bupivacaine, 20 mL/side; n = 44) as part of routine care. Serum IL-6, TNF-α, and IL-10 were measured at baseline, 6 h, and 24 h. Results: Clinically relevant acute pain occurred in 13/44 (29.5%) ITM versus 25/44 (56.8%) ESPB participants (unadjusted risk difference, −27.3 percentage points; 95% CI −44.9 to −6.6). No rescue analgesia was required by 21/44 (47.7%) versus 4/44 (9.1%) (risk difference, 38.6 percentage points; 95% CI 20.2 to 54.0). Mean ObsQoR-11 scores were 95.05 ± 7.49 versus 91.52 ± 6.91 (mean difference, 3.53 points; 95% CI 0.48 to 6.58). Baseline IL-6 and IL-10 concentrations differed; an exploratory baseline-adjusted analysis showed an IL-10 group-by-time interaction after Holm correction. Chronic pain occurred in 3/44 (6.8%) versus 6/44 (13.6%) (risk difference, −6.8 percentage points; 95% CI −20.6 to 6.7). Conclusions: ITM receipt was associated with lower early pain burden and fewer rescue analgesic requirements, but treatment selection was non-randomised and associated with clinician identity. Cytokine findings are exploratory; chronic pain comparisons remain inconclusive.
1 August 2023 in Cyprus Journal of Medical Sciences